Clinical Trial Update: Effect of Alpha-1 Antitrypsin Supplementation on Alcohol-Associated Hepatitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial is investigating whether alpha-1 antitrypsin supplementation can improve outcomes in alcoholic hepatitis. The study is currently not yet …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcoholic Hepatitis

Drugs mentioned

• Alpha-1 Antitrypsin (alpha-1 antitrypsin)

Snippet

Sponsor: Medical University Innsbruck | Conditions: Alcohol-Associated Hepatitis | Phase 2 | Status: NOT_YET_RECRUITING